Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?

References

• Blumel JE, Castelo-Branco C, Binfa L, et al. Quality of life after the menopause: a population study. Maturitas 2000;34:17–23
   PubMed Web of Science ®Google Scholar
• Khosla S. Pathogenesis of age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 2013;68:1226–35
   PubMed Web of Science ®Google Scholar
• Crandall CJ, Barrett-Connor E. Endogenous sex steroid levels and cardiovascular disease in relation to the menopause: a systematic review. Endocrinol Metab Clin North Am 2013;42:227–53
   PubMed Web of Science ®Google Scholar
• Welton AJ, Vickers MR, Kim J, ; WISDOM team. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008;337:a1190
   PubMed Web of Science ®Google Scholar
• Schierbeck L. Primary prevention of cardiovascular disease with hormone replacement therapy. Climacteric 2015;18:492–7
   PubMed Web of Science ®Google Scholar
• Mikkola TS, Tuomikoski P, Lyytinen H, et al. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Menopause 2015;22:976–83
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, ; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Jewett PI, Gangnon RE, Trentham-Dietz A, Sprague BL. Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet Gynecol 2014;124:727–33
   PubMed Web of Science ®Google Scholar
• Shapiro S, Farmer RD, Mueck AO, Seaman H, Stevenson JC. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: Part 2. The Women's Health Initiative: estrogen plus progestogen. J Fam Plann Reprod Health Care 2011;37:165–72
   PubMed Web of Science ®Google Scholar
• Aedo S, Cavada G, Blümel JE, Chedraui P, Fica J, Barriga P. Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. Menopause 2015;22:1317–22
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Barón G, ; Collaborative Group for Research of the Climacteric in Latin America (REDLINC). A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Climacteric 2014;17:433–41
   PubMed Web of Science ®Google Scholar
• Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey. Menopause 2012;19:1088–91
   PubMed Web of Science ®Google Scholar
• Pedersen AT, Iversen OE, Løkkegaard E, et al. Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists. Acta Obstet Gynecol Scand 2007;86:1490–5
   PubMed Web of Science ®Google Scholar
• Birkhäuser MH, Reinecke I. Current trends in hormone replacement therapy: perceptions and usage. Climacteric 2008;11:192–200
   PubMed Web of Science ®Google Scholar
• Devi G, Sugiguchi F, Pedersen AT, Abrassart D, Glodowski M, Nachtigall L. Current attitudes on self-use and prescription of hormone therapy among New York City gynaecologists. Menopause Int 2013;19:121–6
   PubMedGoogle Scholar
• Danckers L, Blümel JE, Witis S, et al. Personal and professional use of menopausal hormone therapy among gynecologists: A multinational study (REDLINC VII). Maturitas 2016;87:67–71
   PubMed Web of Science ®Google Scholar
• Heinemman K, Ruebig A, Potthof P. The Menopause Rating Scale (MRS): a methodological review. Qual Life Res 2004;2:45
   Google Scholar
• http://www.menopause-rating-scale.info/documents/Ref_Values_CountrGr.pdf. Last accessed 27 January 2016
   Google Scholar
• Frank E, Elon L. Clinical and personal relationships between oral contraceptive and hormone replacement therapy use among US women physicians. Menopause 2003;10:133–41
   PubMed Web of Science ®Google Scholar
• Darmon D, Belhassen M, Quien S, Langlois C, Staccini P, Letrilliart L. Factors associated with drug prescription in general practice: a multicenter cross-sectional study. Sante Publique 2015;27:353–62
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Baron G, ; Collaborative Group for Research of the Climacteric in Latin America (REDLINC). A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18:778–85
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Chlebowski RT, Manson JE, ; WHI Investigators. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305:1305–14
   PubMed Web of Science ®Google Scholar
• Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 2007;276:463–9
   PubMedGoogle Scholar
• Schonberg MA, Wee CC. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice. J Womens Health (Larchmt) 2005;14:507–14
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 2007;56:420–8
   PubMed Web of Science ®Google Scholar
• Gentry-Maharaj A, Karpinskyj C, Glazer C, et al. Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause 2015;22:384–90
   PubMed Web of Science ®Google Scholar
• Biglia N, Ujcic E, Kubatzki F, et al. Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial. Maturitas 2006;54:181–92
   PubMed Web of Science ®Google Scholar
• Isaacs AJ, Britton AR, McPherson K. Why do women doctors in the UK take hormone replacement therapy? J Epidemiol Community Health 1997;51:373–7
   PubMed Web of Science ®Google Scholar
• Chaikittisilpa S, Jirapinyo M, Chaovisitsaree S, et al. Impact of Women's Health Initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics. J Med Assoc Thai 2007;90:628–35
   PubMedGoogle Scholar